DE69724780D1 - Polysaccharidschwämme für zellkultur und transplantation - Google Patents

Polysaccharidschwämme für zellkultur und transplantation

Info

Publication number
DE69724780D1
DE69724780D1 DE69724780T DE69724780T DE69724780D1 DE 69724780 D1 DE69724780 D1 DE 69724780D1 DE 69724780 T DE69724780 T DE 69724780T DE 69724780 T DE69724780 T DE 69724780T DE 69724780 D1 DE69724780 D1 DE 69724780D1
Authority
DE
Germany
Prior art keywords
spones
polysaccharid
transplantation
cell culture
mum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69724780T
Other languages
English (en)
Other versions
DE69724780T2 (de
Inventor
Lilia Shapiro
Rachel Glicklis
Smadar Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ben Gurion University of the Negev Research and Development Authority Ltd
Original Assignee
Ben Gurion University of the Negev Research and Development Authority Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd
Application granted granted Critical
Publication of DE69724780D1 publication Critical patent/DE69724780D1/de
Publication of DE69724780T2 publication Critical patent/DE69724780T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A61F2/105—Skin implants, e.g. artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/02—Dextran; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE69724780T 1996-05-22 1997-05-21 Polysaccharidschwämme für zellkultur und transplantation Expired - Lifetime DE69724780T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11837696 1996-05-22
IL11837696A IL118376A0 (en) 1996-05-22 1996-05-22 Polysaccharide sponges for cell culture and transplantation
PCT/IL1997/000161 WO1997044070A1 (en) 1996-05-22 1997-05-21 Polysaccharide sponges for cell culture and transplantation

Publications (2)

Publication Number Publication Date
DE69724780D1 true DE69724780D1 (de) 2003-10-16
DE69724780T2 DE69724780T2 (de) 2004-07-15

Family

ID=11068894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724780T Expired - Lifetime DE69724780T2 (de) 1996-05-22 1997-05-21 Polysaccharidschwämme für zellkultur und transplantation

Country Status (12)

Country Link
US (3) US6425918B1 (de)
EP (1) EP0901384B1 (de)
JP (1) JP2000512666A (de)
AT (1) ATE249251T1 (de)
AU (1) AU714647B2 (de)
CA (1) CA2256327C (de)
DE (1) DE69724780T2 (de)
DK (1) DK0901384T3 (de)
ES (1) ES2206707T3 (de)
IL (1) IL118376A0 (de)
PT (1) PT901384E (de)
WO (1) WO1997044070A1 (de)

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2318577B (en) * 1996-10-28 2000-02-02 Johnson & Johnson Medical Solvent dried polysaccharide sponges
AU3898699A (en) * 1998-05-13 1999-11-29 Regents Of The University Of Michigan, The Sustained dna delivery from structural matrices
IL124957A0 (en) * 1998-06-16 1999-01-26 Univ Ben Gurion Active ingredient delivery systems and devices based on porous matrices
KR100298846B1 (ko) * 1998-09-24 2003-10-22 한국원자력연구소 중화키토산스폰지또는중화키토산/콜라겐혼합스폰지를이용한인공진피
ES2491866T3 (es) * 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Disolución biopolimérica acuosa autogelificante controlada por la temperatura y dependiente del pH
DE19957388A1 (de) * 1999-11-24 2001-06-13 Michael Sittinger Chondroinduktive und implantierbare Substrate zur Knorpelheilung und -protektion
US20020082220A1 (en) * 2000-06-29 2002-06-27 Hoemann Caroline D. Composition and method for the repair and regeneration of cartilage and other tissues
US7214371B1 (en) 2000-09-01 2007-05-08 Ben-Gurion University Of The Negev Research & Development Authority Tissue engineered biografts for repair of damaged myocardium
AU2002230102B9 (en) 2001-01-31 2008-05-01 Seikagaku Corporation Crosslinked polysaccharide sponge
CA2442284C (en) * 2001-04-04 2009-10-06 Delsitech Oy Biodegradable carrier and method for preparation thereof
WO2002092054A2 (en) * 2001-05-11 2002-11-21 Ortho-Mcneil Pharmaceutical, Inc. Immune modulation device for use in animals
JP2003052395A (ja) * 2001-08-09 2003-02-25 Japan Tissue Engineering:Kk 移植適正判定方法
TWI230619B (en) * 2001-08-16 2005-04-11 Ind Tech Res Inst Method of crosslinking of porous biodegradable polymers
WO2003035128A1 (fr) * 2001-10-25 2003-05-01 Japan Science And Technology Agency Substance biologique composite
AU2002351277A1 (en) * 2001-12-06 2003-07-09 Georgia Tech Research Corporation Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
US20040029266A1 (en) * 2002-08-09 2004-02-12 Emilio Barbera-Guillem Cell and tissue culture device
US20040063206A1 (en) * 2002-09-30 2004-04-01 Rowley Jon A. Programmable scaffold and method for making and using the same
US20040147016A1 (en) * 2002-09-30 2004-07-29 Rowley Jonathan A. Programmable scaffold and methods for making and using the same
KR100539371B1 (ko) * 2002-10-21 2005-12-27 메디칸(주) 인체 세포의 체외배양 방법
US20040126405A1 (en) * 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
WO2004067704A2 (en) * 2003-01-30 2004-08-12 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
KR100984184B1 (ko) * 2003-03-18 2010-09-28 에스케이케미칼주식회사 알긴산 스폰지 및 그의 제조방법
WO2004087797A1 (en) * 2003-04-03 2004-10-14 Corporation De L'ecole Polytechnique De Montreal Microporous articles comprising biodegradable medical polymers, method of preparation thereof and method of use thereof
ES2440654T3 (es) 2003-05-05 2014-01-29 Ben-Gurion University Of The Negev Research And Development Authority Preparaciones poliméricas reticuladas inyectables y usos de las mismas
DE10323794A1 (de) * 2003-05-23 2004-12-09 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
JP2005046538A (ja) * 2003-07-31 2005-02-24 Jms Co Ltd 医療用多孔質体およびその製造方法
ATE459379T1 (de) * 2003-09-08 2010-03-15 Fmc Biopolymer As Gel-schaum auf biopolymer-basis
JP2005080927A (ja) * 2003-09-09 2005-03-31 Jms Co Ltd 医療用多孔質体の製造方法
CN100486999C (zh) * 2003-09-12 2009-05-13 生化学工业株式会社 多糖假海绵
JP2007511291A (ja) * 2003-11-13 2007-05-10 シンフォニー メディカル， インコーポレイテッド 心臓の脂肪パッド内の神経伝達の改変による不整脈の制御
US8073538B2 (en) * 2003-11-13 2011-12-06 Cardio Polymers, Inc. Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
WO2005066337A2 (en) * 2004-01-09 2005-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
US20050272153A1 (en) 2004-01-27 2005-12-08 Zou Xuenong Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
US7687619B2 (en) * 2004-02-05 2010-03-30 Millipore Corporation Room temperature stable agarose solutions
WO2005078028A1 (en) * 2004-02-05 2005-08-25 Millipore Corporation Method of forming polysaccharide structures
JP4607522B2 (ja) * 2004-08-31 2011-01-05 焼津水産化学工業株式会社 高分子複合体の製造方法及び該製造方法によって得られる高分子複合体、並びに該高分子複合体を用いた動物細胞の培養方法
BRPI0515973B8 (pt) 2004-10-12 2021-07-27 Fmc Biopolymer As kit para produzir um gel de alginato, composição para preparar um gel e uso
US7514256B2 (en) 2005-02-11 2009-04-07 Emilio Barbera-Guillem Bioreactor for selectively controlling the molecular diffusion between fluids
US9427496B2 (en) 2005-02-18 2016-08-30 Drexel University Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering
US20060239956A1 (en) * 2005-04-26 2006-10-26 Lulu Henson Preparation and use of hydrogels
US20060292690A1 (en) * 2005-06-22 2006-12-28 Cesco Bioengineering Co., Ltd. Method of making cell growth surface
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
ES2804472T3 (es) 2005-12-13 2021-02-08 Harvard College Estructuras para trasplante celular
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
EP1988942B1 (de) * 2006-03-01 2011-07-27 FMC Biopolymer AS Gelierte zusammensetzung
US20080124372A1 (en) * 2006-06-06 2008-05-29 Hossainy Syed F A Morphology profiles for control of agent release rates from polymer matrices
US8168215B2 (en) * 2006-06-16 2012-05-01 Fmc Biopolymer As Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof
BRPI0714386A2 (pt) * 2006-07-14 2012-12-25 Fmc Biopolymer As hidrogel, conta, mÉtodos para produzir um hidrogel ou uma conta, para implantar uma conta ou dispositivo mÉdico implantÁvel e cÉlulas em um paciente, para bloquear vasos sanguÍneos, e para formar um hidrogel, dispositivo mÉdico implantÁvel, formulaÇço de liberaÇço de droga, agente de contraste ou material radioopaco, e, composiÇço terapÊutica embàlica
EP2051661A1 (de) * 2006-09-08 2009-04-29 Symphony Medical, INC. Intramyokardiale strukturierung für globale grössen- und formanpassung des herzens
US20090012413A1 (en) * 2006-09-08 2009-01-08 Sabbah Hani N Cardiac patterning for improving diastolic function
WO2008045506A2 (en) * 2006-10-10 2008-04-17 President And Fellows Of Harvard College Biopolymer structures
AU2007335753B2 (en) * 2006-12-18 2013-12-05 Ben Gurion University Of The Negev Scaffolding for tissue regeneration or repair
US8329870B2 (en) * 2007-01-04 2012-12-11 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
JP2010520766A (ja) * 2007-03-09 2010-06-17 コーニング インコーポレイテッド 細胞培養用三次元ガムマトリックス、製造方法および使用方法
US20080220526A1 (en) * 2007-03-09 2008-09-11 Ellison Adam J Gum coatings for cell culture, methods of manufacture and methods of use
JP2010523264A (ja) * 2007-04-11 2010-07-15 ヘンリー フォード ヘルス システム 心臓の静脈系を用いた心臓の修復、リサイジング、およびリシェイピング
US20090010983A1 (en) * 2007-06-13 2009-01-08 Fmc Corporation Alginate Coated, Polysaccharide Gel-Containing Foam Composite, Preparative Methods, and Uses Thereof
WO2009002401A2 (en) 2007-06-21 2008-12-31 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
AU2008296975B2 (en) * 2007-08-28 2014-07-24 Fmc Corporation Delayed self-gelling alginate systems and uses thereof
IL187707A0 (en) * 2007-11-27 2008-11-03 Univ Ben Gurion Alginate scaffold in hepatectomy
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
EP2254602B1 (de) 2008-02-13 2018-11-21 President and Fellows of Harvard College Kontinuierliche zellprogrammiervorrichtungen
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US20090259210A1 (en) * 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system
WO2009132225A2 (en) * 2008-04-24 2009-10-29 Medtronic, Inc. Rehydratable polysaccharide particles and sponge
CN102159220A (zh) * 2008-04-24 2011-08-17 麦德托尼克公司 硫醇化的壳聚糖凝胶
EP2310002B1 (de) * 2008-04-24 2016-11-02 Medtronic, Inc Schutzgel auf basis von chitosan und oxidiertem polysaccharid
JP2011518837A (ja) * 2008-04-24 2011-06-30 メドトロニック，インコーポレイテッド 再水和可能なチオール化多糖粒子およびスポンジ
CN102883715B (zh) * 2008-04-24 2014-11-12 麦德托尼克公司 包含壳聚糖的保护性组合物
US8735140B2 (en) * 2008-11-07 2014-05-27 Kuehnle Agrosystems, Inc. Preservation and composition of bioprocess algae for production of lipids, seedstock, and feed
WO2010054325A2 (en) * 2008-11-07 2010-05-14 Kuehnle Agrosystems, Inc. Preservation and composition of bioprocess algae for production of lipids, seedstock, and feed
US9297005B2 (en) 2009-04-13 2016-03-29 President And Fellows Of Harvard College Harnessing cell dynamics to engineer materials
US8728456B2 (en) 2009-07-31 2014-05-20 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
KR101760534B1 (ko) * 2009-09-10 2017-07-21 에프엠씨 코포레이션 이음매 없는 알기네이트 캡슐
WO2011109834A2 (en) 2010-03-05 2011-09-09 President And Fellows Of Harvard College Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1
US9226524B2 (en) 2010-03-26 2016-01-05 Philip Morris Usa Inc. Biopolymer foams as filters for smoking articles
WO2011163669A2 (en) 2010-06-25 2011-12-29 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
US11202759B2 (en) 2010-10-06 2021-12-21 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
US9095558B2 (en) 2010-10-08 2015-08-04 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
EP2701753B1 (de) 2011-04-27 2018-12-26 President and Fellows of Harvard College Zellfreundliche inverse und opake hydrogele zur zelleinkapselung, zur arzneimittel- und proteinabgabe sowie für funktionelle nanopartikeleinkapselung
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
EP2701745B1 (de) 2011-04-28 2018-07-11 President and Fellows of Harvard College Injizierbare vorgeformte makroskopische 3d-gerüste für minimal invasive verabreichung
JP6062426B2 (ja) 2011-06-03 2017-01-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ インサイチュー抗原生成癌ワクチン
US9765205B2 (en) 2011-08-24 2017-09-19 Algix, Llc Macrophyte-based bioplastic
WO2013031030A1 (en) 2011-09-01 2013-03-07 L'oreal Cosmetic sheet
ES2773895T3 (es) 2012-04-16 2020-07-15 Harvard College Composiciones de sílice mesoporosa para modular las respuestas inmunitarias
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
WO2014102801A1 (en) 2012-12-30 2014-07-03 Hadasit Medical Research Services And Development Ltd. Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
WO2014169250A1 (en) * 2013-04-11 2014-10-16 President And Fellows Of Harvard College Prefabricated alginate-drug bandages
WO2014191523A2 (en) * 2013-05-29 2014-12-04 Therakine Biodelivery Gmbh Hydrophilic microparticles, drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition
WO2014207578A2 (en) 2013-06-13 2014-12-31 Orgenesis Ltd. Cell populations, methods of transdifferention and methods of use thereof
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
CN104001213B (zh) * 2014-05-07 2016-06-29 广州贝奥吉因生物科技有限公司 一种软骨组织工程用多孔支架及其制备方法
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
MA41296A (fr) 2014-12-30 2017-11-07 Orgenesis Ltd Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
FR3039555B1 (fr) 2015-07-30 2017-08-18 Univ Toulouse Iii - Paul Sabatier Procede de preparation de matrices poreuses polymeres biocompatibles et biodegradables trimensionnelles et applications
CN105169473B (zh) * 2015-10-19 2018-06-29 东南大学 一种超细孔隙水凝胶支架及其制备方法
EP3400074B1 (de) 2016-01-07 2021-10-20 B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University Zusammensetzungen zur erzeugung immuntoleranter reaktionen
CN115531609A (zh) 2016-02-06 2022-12-30 哈佛学院校长同事会 重塑造血巢以重建免疫
AU2017295704B2 (en) 2016-07-13 2023-07-13 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
US10821200B2 (en) * 2016-12-05 2020-11-03 Hyalo Technologies, LLC Method of sterilization of microparticles
WO2018165327A1 (en) 2017-03-08 2018-09-13 Alafair Biosciences, Inc. Hydrogel medium for the storage and preservation of tissue
WO2018207179A1 (en) 2017-05-08 2018-11-15 Orgenesis Ltd. Transdifferentiated cell populations and methods of use thereof
CN108853570B (zh) * 2018-07-16 2021-04-27 浦易（上海）生物技术有限公司 一种止血海绵及其制备方法
WO2020163329A1 (en) 2019-02-05 2020-08-13 Corning Incorporated Woven cell culture substrates
US11118151B2 (en) 2019-11-05 2021-09-14 Corning Incorporated Fixed bed bioreactor and methods of using the same
KR102396513B1 (ko) * 2019-12-30 2022-05-10 조선대학교 산학협력단 버섯의 감마-아미노부티르산 함량 증가용 조성물
EP4090157A4 (de) * 2020-01-13 2023-07-05 The Regents of The University of California Vorrichtungen und verfahren zur hochstabilen superkühlung von wässrigen medien und biologischen materialien
WO2021186982A1 (ja) * 2020-03-17 2021-09-23 日本たばこ産業株式会社 多孔質体の製造方法および多孔質体
WO2021217560A1 (en) 2020-04-30 2021-11-04 L'oreal Kit for caring for the skin

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653383A (en) * 1969-07-30 1972-04-04 Freeze Dry Products Algin sponge and process therefor
FR2167329A1 (en) * 1972-01-13 1973-08-24 Freeze Dry Products Water-absorbent porous algin sponges - readily disposable for medical uses
JPS5571537A (en) * 1978-11-24 1980-05-29 Shin Etsu Chem Co Ltd Method of manufacturing sponge-like molded body
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
JPS5658469A (en) * 1979-10-19 1981-05-21 Yoshinari Masuyama Molding method of glucomannan flour
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
US4522753A (en) * 1980-07-17 1985-06-11 Massachusetts Institute Of Technology Method for preserving porosity in porous materials
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
US4515637A (en) * 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5219361A (en) * 1988-09-16 1993-06-15 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
US5602026A (en) * 1988-10-14 1997-02-11 The General Hospital Corporation Culturing liver cells between two supports
CA2109085C (en) * 1991-04-25 2003-03-11 Keith E. Dionne Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
JPH05125214A (ja) * 1991-11-01 1993-05-21 Komatsu Ltd 超高分子量ポリエチレンポーラス体およびその製造方法
GB9206509D0 (en) * 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
GB9210574D0 (en) * 1992-05-18 1992-07-01 Ca Nat Research Council Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
US5690996A (en) * 1992-11-02 1997-11-25 Sepragen Cross-linked cellulose sponge
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
DE9315877U1 (de) 1993-10-18 1994-01-05 Greenland Gmbh & Co Kg, 78244 Gottmadingen Heuwerbungsmaschine
CA2115592C (en) * 1994-02-14 1998-09-22 Kumiko Kimura Production of glucomannan sponge
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
EP0830381A4 (de) * 1995-06-09 2000-11-22 William N Drohan Chitinhydrogele, herstellungsverfahren und anwendung
US5965125A (en) * 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
US5939323A (en) * 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
GB2318577B (en) * 1996-10-28 2000-02-02 Johnson & Johnson Medical Solvent dried polysaccharide sponges
FI111011B (fi) * 1997-01-15 2003-05-15 Orion Yhtymae Oyj Mikro-organismien kiinteä kasvualusta, sen valmistus ja käyttö
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
EP0991705B1 (de) * 1997-03-31 2003-09-10 The Regents Of The University Of Michigan Offenporige bioabbaubare matrize
WO1999009149A1 (en) * 1997-08-01 1999-02-25 Massachusetts Institute Of Technology Three-dimensional polymer matrices

Also Published As

Publication number Publication date
JP2000512666A (ja) 2000-09-26
ES2206707T3 (es) 2004-05-16
US6793675B2 (en) 2004-09-21
PT901384E (pt) 2004-02-27
EP0901384B1 (de) 2003-09-10
WO1997044070A1 (en) 1997-11-27
DE69724780T2 (de) 2004-07-15
CA2256327A1 (en) 1997-11-27
US20030078672A1 (en) 2003-04-24
US6334968B1 (en) 2002-01-01
US6425918B1 (en) 2002-07-30
CA2256327C (en) 2012-07-24
AU714647B2 (en) 2000-01-06
EP0901384A1 (de) 1999-03-17
AU2711797A (en) 1997-12-09
ATE249251T1 (de) 2003-09-15
IL118376A0 (en) 1996-09-12
DK0901384T3 (da) 2004-01-19

Similar Documents

Publication Publication Date Title
DE69724780D1 (de) Polysaccharidschwämme für zellkultur und transplantation
DE69736813D1 (de) Serum-freie zellkulturmedien
ATE262358T1 (de) Zusammensetzung zur gewebsregeneration
DE69129437T2 (de) Methode zur Anzeige von Sprachpost für zellulare Telephonsysteme
DE69739326D1 (de) Polymerelektrolytmembranen für die verwendung in brennstoffzellen
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
FR2705000B1 (fr) Procédé pour effectuer une combinaison entre un radiotéléphone et une messagerie.
ATE277648T1 (de) Kollagenmembran mit makromolekularer anordnung
DE69005949D1 (de) Interferometrische Vorrichtungen zur Verminderung harmonischer Verzerrungen in Laser-Kommunikationssystemen.
NO982987D0 (no) Amidinoproteasehemmere
BR9405351A (pt) Ação combinada de endoglucanases e celobioidrolases
FR2749022B1 (fr) Cellules aviaires immortelles
MY102966A (en) Improvements in or relating to cephalosporin derivatives
DK0563256T3 (da) Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
DE69604485D1 (de) Topf für selbst-bewässerung
DE69124730D1 (de) Poröses, gasstatisches Lager
DE69111399D1 (de) Chromogenes bestimmungsverfahren für den faktor viii:ca.
WO1993023529A3 (fr) Culture stabilisee d'agregats cellulaires et procede de developpement des embryons a partir d'une souche proembryogene destine a la regeneration de la vigne
FR2657879B1 (fr) Plaque de culture cellulaire.
KR970054728U (ko) 정화조용 미생물 배양상
MX9603722A (es) Nuevos pseudopeptidos sustituidos con heterociclos.
FR2706483B1 (fr) Bioréacteur, destiné notamment à la culture de cellules.
NO902039L (no) Fremgangsmaate ved dyrking av cellekulturer i bioreaktor.
KR880007986U (ko) 메탄가스 발생용 정화조
DE69016783D1 (de) Omega-Carboxyalkohol Oxydase.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN